Market Overview:
The global Moroxydine Hydrochloride market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of infectious diseases, increasing demand for flu and varicella treatments, and growing awareness about the benefits of Moroxydine Hydrochloride. The global Moroxydine Hydrochloride market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into pill form and injection form. The injection form segment is expected to grow at a higher CAGR than the pill form segment during the forecast period from 2018 to 2030. This can be attributed to rising demand for injectable drugs owing to their faster action as compared to oral drugs. On the basis of application,the market is divided into flu treatment, varicella treatment (chickenpox), and others (including wound care).
Product Definition:
Moroxydine Hydrochloride is a medication used to treat urinary tract infections. It is a type of antibiotic known as a quinolone.
Pill:
Pill is a trade name for Moroxydine Hydrochloride which is an antibiotic used to treat bacterial infections. It works by killing the bacteria that causes the infection. The most common types of bacterial infections are pneumonia, urinary tract infection, skin and soft tissue infections, and bloodstream infection. Pill was first approved by the FDA in 1970 for treatment of urea cycle disorders including ornithine transaminase deficiency (OTCD) also called hyposplenism.
Injection:
Injection is a drug form used to treat the common cold, influenza, and allergies. It works by increasing the amount of histamine in the blood stream. The drug was first developed as an anti-allergic medication but later on found out to be effective for treating colds as well.
The global moroxydine hydrochloride market is expected to grow at a significant rate owing to rising incidences of viral infections such as flu.
Application Insights:
The global moroxydine hydrochloride market is segmented by application into flu treatment, varicella treatment, others and unani/homeopathy. The Others segment held the largest share of the overall revenue in 2017 owing to high demand for the drug from various other applications such as chickenpox and zoster infections.
Flu Treatment : This is expected to be the fastest-growing segment over the forecast period due to increasing awareness about influenza viruses among healthcare professionals and patients across all regions globally. Moroxydine has been found effective against both seasonal as well as novel strains of influenza A & B viruses that have been circulating since 2018 including H1N1 (2009), H3N2 (2015), COVID-19 (2018) etc., which are responsible for causing severe disease outbreaks worldwide including pandemic like situations.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing government initiatives for immunization, rising incidence of varicella disease and high adoption of cost-effective drugs. In addition, presence of key manufacturers such as Pfizer Inc.; Merck & Co., Inc.; and Sanofi are contributing towards growth in this region.
Asia Pacific is anticipated to witness lucrative CAGR over the forecast period owing to growing target population base, improving healthcare infrastructure along with rising awareness about available treatment options for common diseases such as chickenpox & shingles and their respective prevention measures like Moroxydine Hydrochloride based medication or Imiquimod cream application which includes Shingles Vaccination Initiative (SVI). Moreover, availability of generic version of brand name drugs at a lower price coupled with favorable government policies aimed at increasing access & coverage rates are some other factors driving regional market growth.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global Moroxydine Hydrochloride market is expected to grow at a CAGR of 5.5% during the forecast period owing to the increasing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pneumonia.
- Growing geriatric population: The global Moroxydine Hydrochloride market is also expected to grow at a CAGR of 5.5% during the forecast period owing to the growing geriatric population who are more susceptible to respiratory diseases.
- Rising awareness about respiratory health: There is an increasing awareness among people about respiratory health and its importance which is driving the growth of the global Moroxydine Hydrochloride market.
- Technological advancements in inhalers: There has been a significant advancement in inhalers technology in recent years which has made them more user-friendly and efficient, thereby driving their demand globally, including in the Moroxydine Hydrochloride market . This is further contributing towards growth of this market during the forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Moroxydine Hydrochloride Market Research Report
By Type
Pill, Injection
By Application
Flu Treatment, Varicella Treatment, Others
By Companies
Anhui Guozheng Pharmaceutical Co., Ltd., Jiangxi Pharmaceutical Co., Ltd., Sunflower Pharmaceutical Group, Yaodu Pharmaceutical Group Co., Ltd., Sinopharm Group Guorui Pharmaceutical Co., Ltd., Hebei Sanshi Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., Chongqing Dikang Changjiang Pharmaceutical Co., Ltd., Xi'an Disai Biological Pharmaceutical Co., Ltd., Baizheng Pharmaceutical Co., Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
221
Number of Tables & Figures
155
Customization Available
Yes, the report can be customized as per your need.
Global Moroxydine Hydrochloride Market Report Segments:
The global Moroxydine Hydrochloride market is segmented on the basis of:
Types
Pill, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Flu Treatment, Varicella Treatment, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Anhui Guozheng Pharmaceutical Co., Ltd.
- Jiangxi Pharmaceutical Co., Ltd.
- Sunflower Pharmaceutical Group
- Yaodu Pharmaceutical Group Co., Ltd.
- Sinopharm Group Guorui Pharmaceutical Co., Ltd.
- Hebei Sanshi Pharmaceutical Co., Ltd.
- Southwest Pharmaceutical Co., Ltd.
- Chongqing Dikang Changjiang Pharmaceutical Co., Ltd.
- Xi'an Disai Biological Pharmaceutical Co., Ltd.
- Baizheng Pharmaceutical Co., Ltd.
Highlights of The Moroxydine Hydrochloride Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pill
- Injection
- By Application:
- Flu Treatment
- Varicella Treatment
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Moroxydine Hydrochloride Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Moroxydine hydrochloride is a medication used to treat depression. It works by increasing the levels of serotonin in the brain.
Some of the major players in the moroxydine hydrochloride market are Anhui Guozheng Pharmaceutical Co., Ltd., Jiangxi Pharmaceutical Co., Ltd., Sunflower Pharmaceutical Group, Yaodu Pharmaceutical Group Co., Ltd., Sinopharm Group Guorui Pharmaceutical Co., Ltd., Hebei Sanshi Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., Chongqing Dikang Changjiang Pharmaceutical Co., Ltd., Xi'an Disai Biological Pharmaceutical Co., Ltd., Baizheng Pharmaceutical Co., Ltd..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Moroxydine Hydrochloride Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Moroxydine Hydrochloride Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Moroxydine Hydrochloride Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Moroxydine Hydrochloride Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Moroxydine Hydrochloride Market Size & Forecast, 2020-2028
4.5.1 Moroxydine Hydrochloride Market Size and Y-o-Y Growth
4.5.2 Moroxydine Hydrochloride Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Pill
5.2.2 Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Flu Treatment
6.2.2 Varicella Treatment
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Moroxydine Hydrochloride Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Moroxydine Hydrochloride Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Pill
9.6.2 Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Flu Treatment
9.10.2 Varicella Treatment
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Pill
10.6.2 Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Flu Treatment
10.10.2 Varicella Treatment
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Pill
11.6.2 Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Flu Treatment
11.10.2 Varicella Treatment
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Pill
12.6.2 Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Flu Treatment
12.10.2 Varicella Treatment
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Pill
13.6.2 Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Flu Treatment
13.10.2 Varicella Treatment
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Moroxydine Hydrochloride Market: Competitive Dashboard
14.2 Global Moroxydine Hydrochloride Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Anhui Guozheng Pharmaceutical Co., Ltd.
14.3.2 Jiangxi Pharmaceutical Co., Ltd.
14.3.3 Sunflower Pharmaceutical Group
14.3.4 Yaodu Pharmaceutical Group Co., Ltd.
14.3.5 Sinopharm Group Guorui Pharmaceutical Co., Ltd.
14.3.6 Hebei Sanshi Pharmaceutical Co., Ltd.
14.3.7 Southwest Pharmaceutical Co., Ltd.
14.3.8 Chongqing Dikang Changjiang Pharmaceutical Co., Ltd.
14.3.9 Xi'an Disai Biological Pharmaceutical Co., Ltd.
14.3.10 Baizheng Pharmaceutical Co., Ltd.
